Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor CellsSergei Boichuk, Aigul Galembikova|Biomedicines|2022Cited by 35
Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 SublineSergei Boichuk, Aigul Galembikova|Diagnostics|2023Cited by 6